Australian Clinical Labs Ltd (AU:ACL) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
UBS Group AG has become a substantial shareholder in Australian Clinical Labs Ltd, with a 6.41% voting power from holding over 12.9 million ordinary shares. This substantial stake highlights UBS’s significant influence in the company, involving various branches and fund management entities across Australia and Switzerland.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.